Cargando…
Can income-based co-payment rates improve disparity? The case of the choice between brand-name and generic drugs
BACKGROUND: Higher income population tend to prefer brand-name to generic drugs, which may cause disparity in access to brand-name drugs among income groups. A potential policy that can resolve such disparity is imposing a greater co-payment rate on high-income enrollees. However, the effects of suc...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824135/ https://www.ncbi.nlm.nih.gov/pubmed/31675967 http://dx.doi.org/10.1186/s12913-019-4598-8 |